This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Best Medical International, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations in Radiopharmaceuticals: The Contributions of Mark Khachaturian
Introduction
Mark Khachaturian is an accomplished inventor based in Knoxville, TN (US). He has made significant strides in the field of radiopharmaceuticals, particularly through his innovative patent that enhances the production and quality control of these critical medical substances.
Latest Patents
Khachaturian holds a patent for an "Automated Radiopharmaceutical Production and Quality Control System." This system integrates a particle accelerator, a radiopharmaceutical micro-synthesis subsystem, and a quality control subsystem. The micro-accelerator is optimized for producing radioisotopes that are essential for synthesizing radiopharmaceuticals in quantities suitable for multiple unit doses. This innovation allows for substantial reductions in size, power requirements, and weight compared to traditional radiopharmaceutical cyclotrons. The micro-synthesis subsystem includes a small volume chemical synthesis system, which comprises a microreactor and/or a microfluidic chip, enabling the synthesis of radiopharmaceuticals in smaller quantities while significantly reducing processing time and the amount of radioisotope needed. The automated quality control subsystem is crucial for testing the composition and characteristics of the radiopharmaceutical, ensuring its safety for injection.
Career Highlights
Khachaturian is currently associated with Best Medical International, Inc., where he continues to develop and refine technologies that advance the field of medical imaging and treatment. His work is pivotal in improving the efficiency and safety of radiopharmaceutical production.
Collaborations
Some of his notable coworkers include Doug Ferguson and Aaron McFarland, who contribute to the collaborative environment that fosters innovation at Best Medical International, Inc.
Conclusion
Mark Khachaturian's contributions to the field of radiopharmaceuticals through his innovative patent demonstrate his commitment to advancing medical technology. His work not only enhances production efficiency but also ensures the safety of radiopharmaceuticals for patient use.